Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMVT
IMVT logo

IMVT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IMVT News

Immunovant Stock Hits Five-Year High Following Positive Trial Results

5d agoYahoo Finance

HCW Biologics Stock Surges 129% Amid Concerns

5d agoNASDAQ.COM

IMVT-1402 Phase 2 Data Shows Strong Response Rates

6d agostocktwits

Immunovant's Phase 2 Trial Results Show Promising Efficacy for IMVT-1402

6d agoseekingalpha

Immunovant Reports Fiscal 2026 Financial Results and Updates on IMVT-1402

6d agoNASDAQ.COM

Immunovant Q4 Earnings Miss Expectations with Significant Cash Reserves

6d agoseekingalpha

Immunovant Set to Announce Q4 Earnings on May 20

May 19 2026seekingalpha

Biotech Landscape Update: Regulatory Approvals and Acquisitions

Apr 03 2026NASDAQ.COM

IMVT Events

05/20 12:10
Immunovant Stock Rises 33.6% to $35.12
Immunovant is up 33.6%, or $8.83 to $35.12.

IMVT Monitor News

Immunovant Reports Q4 Earnings Miss Amid Strong Cash Reserves

May 20 2026

Immunovant Q3 Earnings Beat Expectations with Strong Cash Position

Feb 06 2026

Immunovant Inc raises $550 million for IMVT-1402 launch

Dec 11 2025

IMVT Earnings Analysis

No Data

No Data

People Also Watch